Human Colon Adenocarcinoma in the SCID/CB6 Radiation Chimera Is Susceptible to Adoptive Transfer of Allogeneic Human Peripheral Blood Mononuclear Cells-Reference-Cited by-同舟云学术

Human Colon Adenocarcinoma in the SCID/CB6 Radiation Chimera Is Susceptible to Adoptive Transfer of Allogeneic Human Peripheral Blood Mononuclear Cells

Published:2002-12 Issue:6 Volume:11 Page:883-893
ISSN:1525-8165
Container-title:Journal of Hematotherapy & Stem Cell Research
language:en
Short-container-title:Journal of Hematotherapy & Stem Cell Research

Author:

Arditti Fabian D.¹,Greenberg Ron²,Dekel Benjamin¹,Marcus Hadar¹,Nagler Arnon³,Berrebi Alain⁴,Skornick Yehuda²,Reisner Yair¹

Affiliation:

1. Department of Immunology, Weizmann Institute of Science, Rehovot, Israel

2. Department of Surgery A, Sourasky Medical Center, Tel Aviv, Israel

3. Department of Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Israel

4. Hematology Institute, Kaplan Medical Center, Rehovot

Publisher

Mary Ann Liebert Inc

Subject

Hematology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/152581602321080547

Reference39 articles.

1. Science, medicine, and the future: Cellular immunotherapy for cancer

2. Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.

3. Preservation of chromosome and DNA characteristics of human colorectal adenocarcinomas after passage in nude mice

4. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC);Cancer Immunology, Immunotherapy;2008-06-18

2. Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate;Molecular Cancer Therapeutics;2005-02-01

3. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project;Blood;2004-06-01